Antibiotic resistance in group A streptococci (Q40531584)

21 September 2017

1 reference

title

Antibiotic resistance in group A streptococci (English)

1 reference

21 September 2017

main subject

antibiotic resistance

1 reference

Gerber MA

1

1 reference

21 September 2017

publication date

1 June 1995

1 reference

Pediatric Clinics of North America

21 September 2017

published in

1 reference

21 September 2017

volume

42

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

539-551

1 reference

Discrepancy between minimum inhibitory and minimum bactericidal concentrations of penicillin for group A and group B β-hemolytic streptococci

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Decline of erythromycin resistance of group A beta-hemolytic streptococci in Japan. Comparison with worldwide reports

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Antibiotic susceptibility of group A streptococci: a 6-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Current antibiotic susceptibility of group A beta-hemolytic streptococci.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

The regression line for erythromycin is not valid for beta-hemolytic streptococci group A

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

An epidemic of penicillin-tolerant group A streptococcal pharyngitis in children living in a closed community: mass treatment with erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Preliminary Report of an Outbreak of Streptococcal Disease Caused by a Sulfadiazine Resistant Group A, Type 17 Hemolytic Streptococcus

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Infections with -Hemolytic Streptococcus Resistant to Lincomycin and Erythromycin and Observations on Zonal-Pattern Resistance to Lincomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Experimental approach to the problem of treatment failure with penicillin. I. Group A streptococcal infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

IN VITRO SUSCEPTIBILITY OF GROUP A BETA HEMOLYTIC STREPTOCOCCI TO 18 ANTIBIOTICS

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Susceptibility of Beta-Hemolytic Streptococci to 65 Antibacterial Agents

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Penicillin-resistant and penicillin-tolerant mutants of group A Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Erythromycin resistance in group A beta-hemolytic streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Susceptibility to sulfadiazine of hemolytic streptococci recovered in army camps

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Outbreaks of infections with erythromycin-resistant group A streptococci in child day care centres.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Molecular genetics of resistance to macrolides, lincosamides and streptogramin B (MLS) in streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Susceptibility of group A beta-hemolytic Streptococcus isolates to penicillin and erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Erythromycin resistance in group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Association of penicillin tolerance with failure to eradicate group A streptococci from patients with pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Group A streptococci resistant to clindamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Penicillin tolerant group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Tetracycline resistance of group A beta hemolytic streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Aureomycin and erythromycin therapy for str. pyogenes in burns

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Stepwise acquisition of multiple drug resistance by beta-hemolytic streptococci and difference in resistance pattern by type

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Prevention of rheumatic fever by treatment of previous streptococcic infections; effect of sulfadiazine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Drug Resistance in Streptococcus pyogenes Isolated in Japan (1974–1975)

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Global Surveillance of Antibiotic Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Erythromycin-resistant Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Cephalosporins are superior to penicillin for treatment of streptococcal tonsillopharyngitis: is the difference worth it?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

A community outbreak of group A beta haemolytic streptococci with transferable resistance to erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Resistance to Erythromycin in Group A Streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Efficacy of beta-lactamase-resistant penicillin and influence of penicillin tolerance in eradicating streptococci from the pharynx after failure of penicillin therapy for group A streptococcal pharyngitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Persistence of acute rheumatic fever in the intermountain area of the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Combined resistance to erythromycin and tetracycline in streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Erythromycin-resistant beta-hemolytic streptococci group A in Göteborg, Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

Penicillin tolerance in group A streptococci and treatment failure in streptococcal tonsillitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2816%2938978-7

7 January 2021

10.1016/S0031-3955(16)38978-7

Identifiers

DOI

1 reference

21 September 2017

1 reference